ANNX Annexon Inc
Price (delayed)
$1.84
Market cap
$201.87M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.01
Enterprise value
$180.31M
Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on
Highlights
Annexon's EPS has increased by 43% YoY and by 2.9% QoQ
Annexon's debt has decreased by 8% YoY and by 2.1% from the previous quarter
The equity has grown by 17% year-on-year but it has declined by 12% since the previous quarter
Annexon's quick ratio has decreased by 40% from the previous quarter and by 29% YoY
The company's net income fell by 18% QoQ and by 3% YoY
Key stats
What are the main financial stats of ANNX
Market
Valuations
Earnings
Shares outstanding
109.71M
Market cap
$201.87M
Enterprise value
$180.31M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.67
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$154.07M
Net income
-$138.2M
EBIT
-$138.2M
EBITDA
-$134.75M
Free cash flow
-$118.02M
Per share
Balance sheet
Liquidity
EPS
-$1.01
EPS diluted
-$1.01
Free cash flow per share
-$0.86
Book value per share
$2.75
Revenue per share
$0
TBVPS
$2.55
Total assets
$350.07M
Total liabilities
$56.97M
Debt
$28.97M
Equity
$293.11M
Working capital
$285.95M
Debt to equity
0.1
Current ratio
10.37
Quick ratio
10.26
Net debt/EBITDA
0.16
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-38.4%
Return on equity
-44.3%
Return on invested capital
-53.4%
Return on capital employed
-43.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ANNX stock price
How has the Annexon stock price performed over time
Intraday
-4.66%
1 week
-25.51%
1 month
-30.3%
1 year
-72.25%
YTD
-64.13%
QTD
-4.66%
Financial performance
How have Annexon's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$154.07M
Net income
-$138.2M
Gross margin
N/A
Net margin
N/A
The company's net income fell by 18% QoQ and by 3% YoY
The company's operating income fell by 17% QoQ and by 7% YoY
Growth
What is Annexon's growth rate over time
Valuation
What is Annexon stock price valuation
P/E
N/A
P/B
0.67
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Annexon's EPS has increased by 43% YoY and by 2.9% QoQ
The P/B is 63% lower than the last 4 quarters average of 1.9 and 59% lower than the 5-year quarterly average of 1.7
The equity has grown by 17% year-on-year but it has declined by 12% since the previous quarter
Efficiency
How efficient is Annexon business performance
The return on invested capital has surged by 57% year-on-year and by 7% since the previous quarter
The ROE is up by 33% year-on-year but it has declined by 14% since the previous quarter
ANNX's ROA is up by 28% YoY but it is down by 13% QoQ
Dividends
What is ANNX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ANNX.
Financial health
How did Annexon financials performed over time
Annexon's current ratio has decreased by 40% from the previous quarter and by 30% YoY
Annexon's quick ratio has decreased by 40% from the previous quarter and by 29% YoY
Annexon's debt is 90% less than its equity
The debt to equity has declined by 23% year-on-year but it has grown by 11% since the previous quarter
The equity has grown by 17% year-on-year but it has declined by 12% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.